-+ 0.00%
-+ 0.00%
-+ 0.00%

Apellis Pharmaceuticals Price Target Raised to $48.00/Share From $45.00 by HC Wainwright & Co.

Dow Jones·02/25/2026 12:01:00

Please log in to view news